Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

717 public trials 251 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor trial results

Completed

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

NCT01337765

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +12 more
Locations
  • Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States
  • University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States
  • Pfizer Investigative Site Parkville, Victoria, Australia
  • Pfizer Investigative Site Toronto, Ontario, Canada
View Trial Details
Completed

Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers

NCT03118817

Conditions
Solid Tumor
Locations
  • Korea, Republic of, Gyeonggi-do Seongnam-si, Gyeonggi-do, South Korea
  • Korea, Republic of, Gyeongsangbuk-do Daegu, Gyeongsangbuk-do, South Korea
  • Korea, Republic of, Chungcheongbuk-do Cheongju-si, North Chungcheong, South Korea
  • Korea, Republic of, Seoul Seoul, South Korea
View Trial Details
Completed

A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

NCT01388335

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dijon, France
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France
View Trial Details

Related conditions